Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral erythromycin vs intravenous metoclopramide for feeding intolerance in critically ill patients
TCTR20240626004Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erythromycin, metoclopramide in feeding intolerance, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jan 2025; status: recruiting.
02
Drugs
erythromycinmetoclopramide
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on TCTR20240626004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240626004.